CMO Market in Pharmaceutical Industry Growth, Size, Trends, Analysis Report by Type, Application, Region and Segment Forecast 2022-2026

The CMO market share in the pharmaceutical industry is expected to increase by USD 46.69 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 7.41%.

This CMO market research report of pharmaceutical industry provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers CMO market segmentation in the pharmaceutical industry by service (API manufacturing service and FDF manufacturing service) and geography (Europe, North America, APAC, MEA, and South America). The CMO market report of pharmaceutical industry also offers information on several market vendors, including Almac Group Ltd., Boehringer Ingelheim International GmbH, Cadila Pharmaceuticals Ltd., CMIC HOLDINGS Co. LTD., Curia Inc., Dr. Reddys Laboratories Ltd., Lonza Group Ltd., Lupin Ltd., Pfizer Inc., and Thermo Fisher Scientific Inc. among others.

What will the CMO Market Size in Pharmaceutical Industry be During the Forecast Period?

Download the Free Report Sample to Unlock the CMO Market in Pharmaceutical Industry Size for the Forecast Period and Other Important Statistics

 

CMO Market in Pharmaceutical Industry: Key Drivers and Challenges

The availability of cost-efficient resources in emerging markets is notably driving the CMO market growth in pharmaceutical industry, although factors such as the stereotypical nature of CMOs may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the CMO market in the pharmaceutical industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key CMO Market Driver In Pharmaceutical Industry

One of the key factors driving growth in the CMO market in the pharmaceutical industry is the availability of cost-efficient resources in emerging markets. Countries such as China, India, Brazil, and Mexico have witnessed significant advances in their healthcare infrastructure and technological advances in their drug development processes. As a result, large and medium-sized pharmaceutical companies from developed countries are outsourcing various drugs and therapies' research and manufacturing operations to the vendors in such countries. One of the key reasons for the increasing popularity of outsourcing these processes is the availability of labor at a comparatively lower price than in developed countries. Factors such as the increasing number of US Food and Drugs Association (FDA)-approved manufacturing plants in such countries also encourage outsourcing. Therefore, the global CMO market in the pharmaceutical industry is expected to grow strongly during the forecast period.

Key CMO Market Challenge In Pharmaceutical Industry

The stereotypical nature of CMOs will be a major challenge for the CMO market in pharmaceutical industry during the forecast period. Despite the growing popularity of CMOs in emerging countries such as China and India, the global CMO market in the pharmaceutical industry faces a significant challenge due to the limited offerings of the CMOs vendors. CMOs in Asia, which holds the highest share of the global CMO market in the pharmaceutical industry, lack access to advanced technologies. CMOs in the region primarily manufacture small molecule-based drugs, which can be produced in large quantities. This is mainly due to the complex manufacturing processes of biological drugs, which require advanced technologies. The cost of manufacturing such drugs is also usually high. Many global CMOs operate on a small scale and they lack the funding required to produce biological drugs on a large scale. As a result, the growth opportunity for the small and medium-sized CMOs is restricted to the growth of small molecule-based generic drugs. This is currently a significant challenge faced by CMOs and is expected to hinder the growth of the global CMO market in the pharmaceutical industry.

This CMO market analysis report of pharmaceutical industry also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Who are the Major CMO Market Vendors in Pharmaceutical Industry?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

 

• Almac Group Ltd.
• Boehringer Ingelheim International GmbH
• Cadila Pharmaceuticals Ltd.
• CMIC HOLDINGS Co. LTD.
• Curia Inc.
• Dr. Reddys Laboratories Ltd.
• Lonza Group Ltd.
• Lupin Ltd.
• Pfizer Inc.
• Thermo Fisher Scientific Inc.

 

This statistical study of the CMO market in pharmaceutical industry encompasses successful business strategies deployed by the key vendors. The CMO market in the pharmaceutical industry is fragmented and the vendors are deploying various organic and inorganic growth strategies to compete in the market.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The CMO market forecast report of pharmaceutical industry offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies. 

Which are the Key Regions for CMO Market in Pharmaceutical Industry?

For more insights on the market share of various regions Request for a FREE sample now!

35% of the market's growth will originate from Europe during the forecast period. Germany, France, and the UK are the key markets for CMO in the pharmaceutical industry in Europe. However, the market growth rate in this region will be slower than the growth of the market in the North American, MEA, and APAC regions.

Various small- and medium-sized CMOs are working on offering efficient services at a low cost to pharmaceutical companies by cutting down overhead costs. This will facilitate the CMO market growth in pharmaceutical industry in Europe over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

What are the Revenue-generating Service Segments in the CMO Market in Pharmaceutical Industry?

To gain further insights on the market contribution of various segments Request for a FREE sample

The CMO market share growth in the pharmaceutical industry by the API manufacturing service segment will be significant during the forecast period. The growing collaborations between global pharmaceutical companies and API manufacturers such as CMOs, particularly in India and China, are the driving force behind the segment's growth. The growing interest of large pharmaceutical companies to capitalize on Indian and Chinese strengths of bulk production yields (high volumes at low cost) is another major force driving the growth of the segment. 

This report provides an accurate prediction of the contribution of all the segments to the growth of the CMO market size in pharmaceutical industry and actionable market insights on post COVID-19 impact on each segment.

 

CMO Market Scope in Pharmaceutical Industry
Report Coverage	Details
Page number	120
Base year	2021
Forecast period	2022-2026
Growth momentum & CAGR	Accelerate at a CAGR of 7.41%
Market growth 2022-2026	$ 46.69 billion
Market structure	Fragmented
YoY growth (%)	7.92
Regional analysis	Europe, North America, APAC, MEA, and South America
Performing market contribution	Europe at 35%
Key consumer countries	US, Germany, China, France, and UK
Competitive landscape	Leading companies, Competitive strategies, Consumer engagement scope
Key companies profiled	Almac Group Ltd., Boehringer Ingelheim International GmbH, Cadila Pharmaceuticals Ltd., CMIC HOLDINGS Co. LTD., Curia Inc., Dr. Reddys Laboratories Ltd., Lonza Group Ltd., Lupin Ltd., Pfizer Inc., and Thermo Fisher Scientific Inc.
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this CMO Market Report of Pharmaceutical Industry?

• CAGR of the market during the forecast period 2022-2026
• Detailed information on factors that will drive pharmaceutical CMO market growth during the next five years
• Precise estimation of the pharmaceutical CMO market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the pharmaceutical CMO industry across Europe, North America, APAC, MEA, and South America
• A thorough analysis of the market's competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of pharmaceutical CMO market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch